alkaloid/inflammation

BACKGROUND Monoamine oxidase (MAO) inhibitors can regulate the level of monoamines and their neurotransmitter release in different brain regions and in the body (including dopamine, norepinephrine, and serotonin). MAO inhibitors (MAOI) can thereby affect the modulation of neuroendocrine function,

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to compounds which have more than one pharmaceutically desirable activity. More particularly, the present invention is directed to a newly isolated indole alkaloid compound and analogs thereof which have

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to compounds which have more than one pharmaceutically desirable activity. More particularly, the present invention is directed to a newly isolated indole alkaloid compound and analogs thereof which have

This application is a 35 U.S.C. 371 national stage filing and claims priority to PCT Application No. PCT/IN2014/000201, entitled "Novel Chromone Alkaloid Dysoline for the Treatment of Cancer and Inflammatory Disorders" filed on Mar. 31, 2014, which claims priority to Indian Application No.

This application corresponds to my German Patent application No. P 31 28 018.8, filed on July 13, 1981 which is relied upon and incorporated by reference herein. FIELD OF THE INVENTION The invention is directed to a method for diagnosing and for therapeutic treatment of tumors and infectious

DESCRIPTION The invention relates to anti-inflammation and antimicrobial compositions which can be used in dental and dermatological preparations for both medicinal and cosmetic purposes. More in particular, the invention relates to pharmaceutical compositions for the treatment of prevention of

FIELD OF THE INVENTION The subject invention pertains to compounds which are useful as anti-inflammatory agents and to compositions containing such compounds as active ingredients. More particularly, the invention concerns novel uses for biologically active bis-heterocyclic compounds, e.g.

BACKGROUND OF THE INVENTION 1. Field of the Invention The subject invention pertains to compounds that are useful as anti-inflammatory agents and to compositions containing such compounds as active ingredients. More particularly, the invention concerns novel uses for biologically active

FIELD OF THE INVENTION The subject invention pertains to compounds which are useful as anti-inflammatory agents and to compositions containing such compounds as active ingredients. More particularly, the invention concerns novel uses for biologically active bis-heterocyclic compounds, e.g.

FIELD OF THE INVENTION This application relates to compounds which are used as anti-inflammatory agents and compositions containing such compounds as active ingredients. More particularly, the invention concerns a novel use of biologically active bis-heterocyclic compounds, e.g., bis-indoles,

I. FIELD OF THE INVENTION This application relates to the preparation of a biomimetic mixture of compounds that ameliorates inflammatory effects caused by environmental and physiological conditions. In particular, the mixture biomimics an extract prepared from the fruit of Evodia rutaecarpa. The

FIELD OF THE INVENTION The present invention relates generally to a composition and method for ameliorating pain and inflammation. More particularly, the present invention relates to a pain and inflammation ameliorating composition, which contains an alkaloid compound extracted from an Aconitum

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to alkaloid aminoester derivatives, which act as muscarinic receptor antagonists. The present invention also relates to processes for preparing such a compound and compositions which contain such a compound. The

CROSS REFERENCES TO RELATED APPLICATIONS This application claims priority to European Patent Application No. 08172818.0, filed on Dec. 23, 2008, which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to alkaloid

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to compounds which have more than one pharmaceutically desirable activity. More particularly, the present invention is directed to a newly isolated indole alkaloid compound and analogs thereof which have